Home › Funds › HIGHBRIDGE CAPITAL MANAGEMENT LLC › SRPT
HIGHBRIDGE CAPITAL MANAGEMENT LLC position in SRPT
SAREPTA THERAPEUTICS INC · Health Care
HIGHBRIDGE CAPITAL MANAGEMENT LLC reported holding 52,306,000 shares of SRPT (SAREPTA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$49.3M, representing 1.99% of its reported portfolio and ranking #12 among its reported holdings. HIGHBRIDGE CAPITAL MANAGEMENT LLC has disclosed SRPT holdings in 11 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How HIGHBRIDGE CAPITAL MANAGEMENT LLC's SRPT position evolved
HIGHBRIDGE CAPITAL MANAGEMENT LLC first disclosed a stake in SRPT in Q3 2023 at 31,000,000 shares (US$34.8M). The position peaked in Q4 2023 at 50,000,000 shares, worth US$50.77B. Across 11 filings, HIGHBRIDGE CAPITAL MANAGEMENT LLC increased the stake 4 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 52,306,000 shares valued at US$49.3M — an increase of 52,056,000 shares quarter over quarter.. Notable position changes include a 61% increase in Q4 2023 (shares rose 34% over the following quarter), a 99% trim in Q4 2025 (shares rose 1% over the following quarter), a 20822% increase in Q2 2026 (shares rose 1% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 31.00M | $34.77M | New |
| Q4 2023 | 50.00M | $50.77B | Add |
| Q2 2024 | 45.00M | $58.18M | New |
| Q3 2024 | 60.00M | $68.19M | Add |
| Q4 2024 | 57.50M | $63.35M | Reduce |
| Q1 2025 | 38.00M | $35.40M | Reduce |
| Q2 2025 | 40.00M | $29.63M | Add |
| Q3 2025 | 37.00M | $32.56M | Reduce |
| Q4 2025 | 400.00K | $8.61M | Reduce |
| Q1 2026 | 250.00K | $5.12M | Reduce |
| Q2 2026 | 52.31M | $49.27M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SRPT and 13F data
SRPT (SAREPTA THERAPEUTICS INC) is a Health Care company. 11 other funds we track also report a position in SRPT. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
More on HIGHBRIDGE CAPITAL MANAGEMENT LLC
FAQ
How long has HIGHBRIDGE CAPITAL MANAGEMENT LLC held SRPT?
HIGHBRIDGE CAPITAL MANAGEMENT LLC has disclosed SRPT holdings in 11 of the last 12 reported quarters, going back to Q3 2023.
What is HIGHBRIDGE CAPITAL MANAGEMENT LLC's current position in SRPT?
As of Q2 2026, HIGHBRIDGE CAPITAL MANAGEMENT LLC holds 52.31M shares of SRPT (SAREPTA THERAPEUTICS INC), valued at $49.27M, representing 1.99% of its reported portfolio and ranking #12.
Has HIGHBRIDGE CAPITAL MANAGEMENT LLC been buying or selling SRPT?
In the latest 13F filing (Q2 2026), HIGHBRIDGE CAPITAL MANAGEMENT LLC increased its position in SRPT. The position peaked in Q4 2023 at 50.00M shares.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.